A case of extensive linear porokeratosis with evaluation of topical tretinoin versus 5-flourouracil as treatment modalities

Journal of Dermatology

Volumn 32, Issue 12, 2005, Pages 1000-1004

  Grover, Chander ^a,b   Goel, Alka ^a   Nanda, Soni ^a   Khurana, Nita ^a   Reddy, Belum Siva Nagi ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

Flourouracil; Linear porokeratosis; Tretinoin

Indexed keywords

FLUOROURACIL; RETINOIC ACID;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COSMETIC INDUSTRY; DRUG SAFETY; EXFOLIATIVE DERMATITIS; HISTOPATHOLOGY; HUMAN; HYPERPIGMENTATION; MALE; POROKERATOSIS; PRURITUS; SKIN BIOPSY; ULCER;

EID: 32944464728     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00890.x     Document Type: Article

References (14)

1. Arranz-Salaz I, Sanz-Trelles A, Bautista Ojeda D: p53 alterations in porokeratosis, J Cutan Pathol, 30: 455-458, 2003.
2. Ito M, Fujuetara H, Maruyama T: Morphogenesis of the cornoid lamella: histochemical, immunohistochemical and ultrastructural study of porokeratosis, J Cutan Pathol, 18: 247-256, 1991.
3. Webster FG: Are porokeratoses an infection?, Arch Dermatol, 137: 665, 2001.
4. Chernosky ME: Porokeratosis, Arch Dermatol, 122: 869-870, 1986.
5. Balato N, DiNardo G, Boccia L, Nappa P: Linear Mibelli's porokeratosis. Treatment with topical 5-flourouracil, G Ital Dermatol Venereol, 121: 147-148, 1986.
6. Harrison S, Sinclair R: Porokeratosis of Mibelli: Successful treatment with topical 5% imiquimod cream, Australas J Dermatol, 44: 281-283, 2003.
7. Taniguchi Y, Yuasa T, Shimiza M: Linear porokeratosis, J Dermatol, 20: 489-492, 1993.
8. Wolff-Schteiner EC: Porokeratosis, in Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB (eds): Fitzpatrick's Dermatology in General Medicine 5th ed, Vol I, McGraw Hill, New York, 1999, pp 624-629.
9. Agarwal SK, Gandhi V, Madan V, Bhattacharya SN: Topical tretinpoin in an Indian male with zosteriform porokeratosis, Int J Dermatol, 42: 919-920, 2003.
10. Freyschmidt-Paul P, Hoftman R, Konig A, Happle R: Linear porokeratosis superimposed on disseminated superficial actinic porokeratosis: Report of two cases, exemplifying the concept of type 2 segmental manifestation of autosomal dominant skin disorders, J Am Acad Dermatol, 41: 644-647, 1999.
11. Chen HH, Lioo YH: Onychodystrophy in congenital linear porokeratosis, Br J Dermatol, 147: 1272-1273, 2002.
12. Prystowsky JH: Topical Retinoids, in Wolverton SE (ed): Comprehensive Dermatologic Therapy, WB Saunder Company, Philadelphia, 2001, pp 578-594.
13. Zackheim HS: Topical and intralesional chemotherapeutic agents, in Wolverton SE (ed): Comprehensive Dermatologic Therapy, WB Saunder Company, Philadelphia, 2001, pp 595-606.
14. Nahm WK, Donohue KG, Danahy JF, Badlavas E, Falanga V: Systemic 5-flourouracil producing an inflammatory response in porokeratosis, JEADV, 17: pp 190-192, 2003.